Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

Completed · Phase 3 · Has a placebo group

Conditions studied: Polycystic Ovary Syndrome

In brief

Oral contraceptives are known to improve menstrual cycles and symptoms in PCOS, however may increase cholesterol. Metformin, a drug to improve insulin resistance, may benefit metabolic state. This study is to determine whether metformin added to oral contraceptive therapy in adolescent women with PCOS improves metabolic state.The study will also test a lifestyle improvement program to reduce weight.

Key facts

Study ID

NCT00283816

Run by

University of Rochester

People needed

36

Starts

2006-01-01

Expected to finish

2008-01-01

Last updated by the study team

2015-05-15

Who can join

Age: 12 and older, up to 18. Sex: female. Healthy volunteers: accepted.

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.